"Bidi" Phoenix streptococcal identification and drug susceptibility test agent-9
Taiwan·Risk Class 2·BECTON DICKINSON AND COMPANY(BD)·Registered Jul 25, 2008 – Jul 25, 2023Expired- Analysis ID
- 9a1cc4f49f9c2c106fc2fff8ae3c291a
- Customs Code
- DHA00601941603
- Manufacturer
- BECTON DICKINSON AND COMPANY(BD)
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- The Phoenix SMIC/ID kit contains selective antimicrobials for rapid identification and drug tolerability testing against most human sources of streptococci. This kit can only be used with the Phoenix Automated Microbiology System instrument.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- import
- Registration Date
- Jul 25, 2008
- Expiry Date
- Jul 25, 2023
Access comprehensive regulatory information for "Bidi" Phoenix streptococcal identification and drug susceptibility test agent-9 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9a1cc4f49f9c2c106fc2fff8ae3c291a and manufactured by BECTON DICKINSON AND COMPANY(BD). The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.